(*corresponding author)

  • Cooper CG, Kafetzis KN, Patabendige A*, Tagalakis AD* (2024). Blood-brain barrier disruption in dementia: Nano-solutions as new treatment options. Eur J Neurosci. 59(6):1359-1385.
Nanoparticles decorative image.
Formulation of a nanoparticle with potential to cross the blood-brain barrier and the targeted effect of nanoparticles within the brain
  • Patabendige A* (2022). An improved in vitro porcine blood-brain barrier model for permeability screening and functional studies. Methods Mol Biol. 2492:131-142.
Brain cells image.
            Brain endothelial cell migration from isolated brain capillaries
  • Aryal R and Patabendige A* (2021). Blood-brain barrier disruption in atrial fibrillation: a potential contributor to the increased risk of dementia and worsening of stroke outcomes? Open Biol. 11(4):200396.
  • Patabendige A*, Michael BD, Craig AG, Solomon T (2018). Brain microvascular endothelial-astrocyte cell responses following Japanese encephalitis virus infection in an in vitro human blood-brain barrier model. Mol Cell Neurosci. 89:60-70.
Japanese virus
Image: Japanese encephalitis virus (JEV) infection of the BBB induces a strong pro-inflammatory response from host cells
  • Patabendige A*, Skinner RA, Abbott NJ* (2013). Establishment of a simplified in vitro porcine blood-brain barrier model with high transendothelial electrical resistance. Brain Res. 1521:1-15.
Image: Immunocytochemical localisation of occludin and claudin-5 in porcine brain endothelial cells and microvessels.